Endo International Plc (ENDP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Endo International Plc (ENDP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7308
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies. It sells generic products principally in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women’s health, among others. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrinology and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors, to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc (ENDP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Endo International Plc, Medical Equipment, Deal Details 11
Private Equity 11
Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For US$130 Million 11
Partnerships 12
Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12
Debt Offering 13
Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13
Auxilium Pharma Completes Public Offering Of Notes Due 2018 For US$350 Million 14
Asset Transactions 15
Trendlines Acquires Intellectual Property from Endo 15
Acquisition 16
Par Formulations to Acquire Wintac 16
Par Pharma Acquires Innoteq for USD27 Million 17
Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18
Endo Health Solutions Completes Acquisition Of Paladin Labs For US$1.6 Billion 19
Par Pharma Acquires JHP Group for USD488 Million 22
Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23
Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24
Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For US$26.2 Million 25
Endo International Plc – Key Competitors 26
Endo International Plc – Key Employees 27
Endo International Plc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
Strategy And Business Planning 31
Jul 21, 2017: Endo to Restructure Manufacturing Network 31
Financial Announcements 32
Aug 08, 2018: Endo reports second-quarter 2018 financial results 32
May 08, 2018: Endo Reports First-Quarter 2018 Financial Results 34
Feb 27, 2018: Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results 36
Nov 09, 2017: Endo Reports Third-Quarter 2017 Financial Results 38
Aug 08, 2017: Endo Reports Second-Quarter 2017 Financial Results 40
May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 42
Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 45
Corporate Communications 48
Aug 02, 2018: Endo announces appointment of Laure Park as senior vice president investor relations and corporate affairs 48
Nov 08, 2017: Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram 49
Legal and Regulatory 50
Apr 02, 2018: Endo Agrees to Extend Temporary Stay of FDA Litigation 50
Aug 07, 2017: Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims 51
Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 52
Other Significant Developments 53
Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Endo International Plc, Medical Equipment, Key Facts, 2017 2
Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endo International Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endo International Plc, Deals By Market, 2012 to YTD 2018 9
Endo International Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For US$130 Million 11
Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12
Endo International Prices Private Placement of 5.875% Notes Due 2024 for USD300 Million 13
Auxilium Pharma Completes Public Offering Of Notes Due 2018 For US$350 Million 14
Trendlines Acquires Intellectual Property from Endo 15
Par Formulations to Acquire Wintac 16
Par Pharma Acquires Innoteq for USD27 Million 17
Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 18
Endo Health Solutions Completes Acquisition Of Paladin Labs For US$1.6 Billion 19
Par Pharma Acquires JHP Group for USD488 Million 22
Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 23
Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 24
Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For US$26.2 Million 25
Endo International Plc, Key Competitors 26
Endo International Plc, Key Employees 27
Endo International Plc, Other Locations 29
Endo International Plc, Subsidiaries 29

List of Figures
Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Endo International Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endo International Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Endo International Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endo International Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Endo International Plc (ENDP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hofseth Biocare ASA:企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Reed’s, Inc. (REED):企業の財務・戦略的SWOT分析
    Summary Reed's Inc (Reed) is manufacturer and distribution of non-alcoholic carbonated soft drinks, candies and beverages. The company's product portfolio include Reed's ginger brew, wellness ginger shots, zero sugar, and ginger candies It brews carbonated ginger in various flavors including extra g …
  • Cre8tek Ltd (FGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Cre8tek Ltd (Cre8tek), formerly Marion Energy Ltd, is an oil and gas exploration and production company. The company explores, acquires, develops, produces and markets oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek also holds interest in the addi …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • VPK Packaging Group NV:企業の戦略・SWOT・財務情報
    VPK Packaging Group NV - Strategy, SWOT and Corporate Finance Report Summary VPK Packaging Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Marina Portoroz d.d.:企業の戦略・SWOT・財務情報
    Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical products manufacturing company. The company offers products such as aczone, airomir, aldara, benzaclin topical gel, benzamycin, biacna topical gel, C.E.S. tablets, carbolith, ca …
  • Taiflex Scientific Co., Ltd. (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co., Ltd. (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Television Broadcasts Limited (511):企業の財務・戦略的SWOT分析
    Television Broadcasts Limited (511) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Verily Life Sciences LLC-医療機器分野:企業M&A・提携分析
    Summary Verily Life Sciences LLC (Verily), formerly known as Google Life Sciences LLC, a subsidiary of Alphabet Inc is a life sciences research and engineering organization which develops tools for prevention, detection, and management of diseases. The company develops tools for various projects, su …
  • Upstream Medical Technologies Ltd:企業の製品パイプライン分析2018
    Summary Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for diagnoses of unstable angina, CVD, ACS, and others. It provides pipe line product such …
  • Qualcomm Incorporated (QCOM):医療機器:M&Aディール及び事業提携情報
    Summary Qualcomm Incorporated (Qualcomm) is a technology and communication company. The company designs and manufactures digital wireless telecommunications products and services. Qualcomm offers integrated circuits and system software for wireless mobile devices. The major technologies such as code …
  • Dynavax Technologies Corp (DVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Dynavax Technologies Corp (Dynavax), formerly Double Helix Corp, is a clinical-stage biopharmaceutical company that develops product candidates for the prevention of infectious and inflammatory disease. The company’s only marketed product Heplisav-B is an adult vaccine for hepatitis B. Its p …
  • Huaneng Power International, Inc.:企業の戦略・SWOT・財務情報
    Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Sotera Health LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Range Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Range Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and …
  • Technical University of Denmark:製薬・医療:M&Aディール及び事業提携情報
    Summary Technical University of Denmark (DTU) is an educational and research service provider. The university offers undergraduate programs, graduate programs, PhD programs, BSc programs, MSc programs, guest student services, accommodation services and others. It conducts research programs in the ar …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆